These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15689824)

  • 1. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Gandorfer A; Kampik A
    Retina; 2005; 25(2):232-3; author reply 233-4. PubMed ID: 15689824
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
    Men G; Peyman GA; Genaidy M; Kuo PC; Ghahramani F; Blake DA; Bezerra Y; Naaman G; Figueiredo E
    Retina; 2004 Apr; 24(2):199-209. PubMed ID: 15097878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment.
    Unal M; Peyman GA
    Retina; 2000; 20(1):69-75. PubMed ID: 10696751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.
    Stefánsson E
    Retina; 2008 Oct; 28(8):1175-6; author reply 1176. PubMed ID: 18664934
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficient vitreolysis by combining plasmin and sulfur hexafluoride injection in a preclinical study in rabbit eyes.
    Wu WC; Liu CH; Chen CC; Wang NK; Chen KJ; Chen TL; Hwang YS; Li LM; Lai CC
    Mol Vis; 2012; 18():2361-70. PubMed ID: 23049236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin treatment accelerates vascular endothelial growth factor clearance from rabbit eyes.
    Wu WC; Chen CC; Liu CH; Wang NK; Chen KJ; Chen TL; Hwang YS; Li LM; Lai CC
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6162-7. PubMed ID: 21245395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator.
    Chen W; Huang X; Ma XW; Mo W; Wang WJ; Song HY
    Eye (Lond); 2008 Feb; 22(2):300-7. PubMed ID: 17704761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination of lys-plasminogen and urokinase in subpopliteal acute ischemia. Preliminary results].
    Girand C; Tasrini J; Joffre F; Vandenbroek MD; Cerene A
    Presse Med; 1985 Feb; 14(5):281-2. PubMed ID: 3157112
    [No Abstract]   [Full Text] [Related]  

  • 9. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous.
    Hikichi T; Yanagiya N; Kado M; Akiba J; Yoshida A
    Retina; 1999; 19(1):55-8. PubMed ID: 10048374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy.
    Chen W; Mo W; Sun K; Huang X; Zhang YL; Song HY
    Curr Eye Res; 2009 Dec; 34(12):1057-64. PubMed ID: 19958125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research update of ocriplasmin for symptomatic vitreomacular adhesion].
    Zhang M; Chen Y
    Zhonghua Yan Ke Za Zhi; 2014 Nov; 50(11):866-70. PubMed ID: 25582211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocriplasmin (Jetrea) for vitreomacular adhesion.
    Med Lett Drugs Ther; 2013 Aug; 55(1422):63-4. PubMed ID: 23917386
    [No Abstract]   [Full Text] [Related]  

  • 13. [Local perfusion of fibrinolytics in the treatment of priapism].
    Dalery F; Follea G; Rochette M; Bertin-Maghit M; Gelet A; Py G; Berger E; Tissot E
    Cah Anesthesiol; 1986; 34(2):163-5. PubMed ID: 3719422
    [No Abstract]   [Full Text] [Related]  

  • 14. Microplasmin for vitreomacular traction.
    Udaondo P; Diaz-Llopis M; Garcia-Delpech S; Salom D; Arevalo JF
    Ophthalmology; 2010 Sep; 117(9):1859, 1859.e1; author reply 1859-60. PubMed ID: 20816250
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.
    Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings.
    Freitag HJ; Becker VU; Thie A; Tilsner V; Philapitsch A; Schwarz HP; Webhof U; Müller A; Zeumer H
    Neuroradiology; 1996 Feb; 38(2):181-5. PubMed ID: 8692437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
    Naito I
    Rinsho Ketsueki; 1984 Jul; 25(7):1027-35. PubMed ID: 6389929
    [No Abstract]   [Full Text] [Related]  

  • 18. Posterior vitreous detachment induced by microplasmin.
    Gandorfer A; Rohleder M; Sethi C; Eckle D; Welge-Lüssen U; Kampik A; Luthert P; Charteris D
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):641-7. PubMed ID: 14744909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment.
    Mori K; Saito S; Gehlbach PL; Yoneya S
    Ophthalmology; 2007 Jan; 114(1):127-33. PubMed ID: 17070585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local low-dose thrombolytic treatment with sequential urokinase-plasminogen in deep central venous thrombosis].
    Robert D; Fournel P; Holzapfel L; Mercatello A; Guérin C; Vandenbroek MD
    Rev Med Interne; 1984 Sep; 5(3):263-7. PubMed ID: 6505433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.